125 related articles for article (PubMed ID: 22646987)
21. Control of mucus secretion and ion transport in airways.
Nadel JA; Davis B; Phipps RJ
Annu Rev Physiol; 1979; 41():369-81. PubMed ID: 373597
[TBL] [Abstract][Full Text] [Related]
22. A reappraisal of the mucoactive activity and clinical efficacy of bromhexine.
Zanasi A; Mazzolini M; Kantar A
Multidiscip Respir Med; 2017; 12():7. PubMed ID: 28331610
[TBL] [Abstract][Full Text] [Related]
23. Mucolytic agents and mucociliary activity.
Gunnarsson M; Hybbinette JC; Mercke U
Rhinology; 1984 Dec; 22(4):223-31. PubMed ID: 6151739
[TBL] [Abstract][Full Text] [Related]
24. Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?
Scaglione F; Petrini O
Clin Med Insights Ear Nose Throat; 2019; 12():1179550618821930. PubMed ID: 30670922
[TBL] [Abstract][Full Text] [Related]
25. Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential.
Kido H; Okumura Y; Yamada H; Mizuno D; Higashi Y; Yano M
Biol Chem; 2004 Nov; 385(11):1029-34. PubMed ID: 15576322
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of lung maturity: investigation of ambroxol in various animal models.
von Seefeld H; Weiss JM; Eberhardt H
Acta Physiol Hung; 1985; 65(3):305-12. PubMed ID: 3839344
[TBL] [Abstract][Full Text] [Related]
27. Antiinflammatory properties of ambroxol.
Beeh KM; Beier J; Esperester A; Paul LD
Eur J Med Res; 2008 Dec; 13(12):557-62. PubMed ID: 19073395
[TBL] [Abstract][Full Text] [Related]
28. Normalization of bronchial exocrine pathology after endobronchial treatment with ambroxol.
Aliperta A; Bellissimo U; Turco D; Antinolfi G
Int J Tissue React; 1986; 8(2):167-74. PubMed ID: 2939036
[TBL] [Abstract][Full Text] [Related]
29. Evaluating the efficacy of mucoactive aerosol therapy.
Fuloria M; Rubin BK
Respir Care; 2000 Jul; 45(7):868-73. PubMed ID: 10926385
[TBL] [Abstract][Full Text] [Related]
30. [Mucoactive therapy and new aspects of the pathogenesis of chronic obstructive pulmonary disease].
Kobylianskiĭ VI; Gamal' EA
Klin Med (Mosk); 2006; 84(8):15-24. PubMed ID: 17087186
[TBL] [Abstract][Full Text] [Related]
31. The SH-metabolite I of erdosteine, a mucolytic drug, enhances the inhibitory effect of salbutamol on the respiratory burst of neutrophils.
Dal Sasso M; Bovio C; Culici M; Fonti E; Braga PC
Drugs Exp Clin Res; 2002; 28(4):147-54. PubMed ID: 12512232
[TBL] [Abstract][Full Text] [Related]
32. Use of ambroxol and bromhexine as mucolytics for enhanced diffusion of furaltadone into tracheobronchial secretions in broilers.
Sumano H; Gracia I; Capistrán A; Meade G; Rivero A; Ruiz-Ramírez L
Br Poult Sci; 1995 Jul; 36(3):503-7. PubMed ID: 7583380
[TBL] [Abstract][Full Text] [Related]
33. Influence of ambroxol on tracheobronchial clearance in simple chronic bronchitis.
Ericsson CH; Juhász J; Mossberg B; Philipson K; Svartengren M; Camner P
Eur J Respir Dis; 1987 Mar; 70(3):163-70. PubMed ID: 3569448
[TBL] [Abstract][Full Text] [Related]
34. The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells.
Varelogianni G; Hussain R; Strid H; Oliynyk I; Roomans GM; Johannesson M
Cell Biol Int; 2013 Nov; 37(11):1149-56. PubMed ID: 23765701
[TBL] [Abstract][Full Text] [Related]
35. Ambroxol plus amoxicillin in the treatment of exacerbations of chronic bronchitis.
Peralta J; Poderoso JJ; Corazza C; Fernández M; Guerreiro RB; Wiemeyer JC
Arzneimittelforschung; 1987 Aug; 37(8):969-71. PubMed ID: 3675696
[TBL] [Abstract][Full Text] [Related]
36. Action of N-acylated ambroxol derivatives on secretion of chloride ions in human airway epithelia.
Yamada T; Takemura Y; Niisato N; Mitsuyama E; Iwasaki Y; Marunaka Y
Biochem Biophys Res Commun; 2009 Mar; 380(3):586-90. PubMed ID: 19285005
[TBL] [Abstract][Full Text] [Related]
37. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
38. A new paradigm in respiratory hygiene: modulating respiratory secretions to contain cough bioaerosol without affecting mucus clearance.
Zayas G; Valle JC; Alonso M; Alfaro H; Vega D; Bonilla G; Reyes M; King M
BMC Pulm Med; 2007 Aug; 7():11. PubMed ID: 17697323
[TBL] [Abstract][Full Text] [Related]
39. Ambroxol decreases bronchial hyperreactivity.
Melillo G; Cocco G
Eur J Respir Dis; 1986 Nov; 69(5):316-20. PubMed ID: 3539631
[TBL] [Abstract][Full Text] [Related]
40. TRP channels as therapeutic targets in airway disorders: a patent review.
Preti D; Szallasi A; Patacchini R
Expert Opin Ther Pat; 2012 Jun; 22(6):663-95. PubMed ID: 22667456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
